Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: A randomized controlled trial

Age and Ageing

Volumn 27, Issue 6, 1998, Pages 715-722

  Provinciali, Mauro ^c   Montenovo, Alessio ^c   Di Stefano, Giuseppina ^c   Colombo, Mauro ^a   Daghetta, Laura ^a   Cairati, Marco ^a   Veroni, Claudio ^a   Cassino, Roberto ^a   Della Torre, Fabrizio ^c   Fabris, Nicola ^b  

^a Camillo Golgi Geriatric Institute   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c INRCA   (Italy)

Author keywords

Immune response; Influenza vaccine; Randomized controlled trial; Zinc

Indexed keywords

ARGININE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INFLUENZA VACCINE; VIRUS ANTIGEN; ZINC;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERIATRICS; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREACTIVITY; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; ZINC BLOOD LEVEL;

RNA VIRUSES;

EID: 0031791782     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/27.6.715     Document Type: Article

References (37)

1. Patriarca PA, Weber JA, Parker RA et al. Efficacy of influenza vaccine in nursing homes. J Am Med Assoc 1985; 253: 1136-9.
2. Howells CHL, Vesselinova-Jenkins CK, Evans AD et al. Influenza vaccination and mortality from broncopneumonia in the elderly. Lancet 1975; 15: 381-3.
3. Strassburg MA, Greenland S, Sorvillo FJ et al. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4: 38-44.
4. Phair J, Kaufmann CA, Bjornson A. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function J Lab Clin. Med 1978; 92: 822-5.
5. Provinciali M, Di Stefano G, Muzzioli M et al. Impaired antibody response to influenza vaccine in institutionalized elderly. In Fabris N, Harman D, Kitani K, Zs-Nagy I eds. Pharmacology of Aging Processes: methods of assessment and potential interventions. Ann NY Acad Sci 1994; 717: 307-74.
6. Kishimoto S, Tomino S, Mitsuya H et al. Age-related decline in the in vivo and in vitro synthesis of anti-tetanus toxoid antibody in humans. J Immunol 1980; 5: 2347-51.
7. Powers DC. Immunological principles and emerging strategies of vaccination for the elderly. J Am Geriatr Soc 1992; 40: 81-94.
8. Gravenstein S, Duthie EH, Miller BA et al. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo controlled clinical study. J Am Geriatr Soc 1989; 37: 1-8.
9. Provinciali M, Di Stefano G, Colombo M et al. Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects. Mech Ageing Dev 1994; 77: 75-82.
10. Profeta ML, Guidi G, Meroni PL et al. Influenza vaccination with adjuvant RU41740 in the elderly. Lancet 1987; 8539: 973.
11. Lesourd BM, Vincent-Falquet JC, Deslandes D et al. Influenza vaccination in the elderly: improved antibody response with imuthiol (NA diethyldithiocarbamate) adjuvant therapy. Int J Immunopharmacol 1988; 10: 135-43.
12. Fabris N, Mocchegiani E. Zinc, human diseases and aging. Aging Clin Exp Res 1995; 7: 77-93.
13. Stafford W, Smith RG, Lewis SJ et al. A study of zinc status of elderly institutionalised patients. Age Ageing 1988; 17: 42-6.
14. Sahyoun NR, Otradovec CL, Hartz SC et al. Dietary intakes and biochemical indicators of nutritional status in an elderly, institutionalised population. Am J Clin Nutr 1988; 47: 524-9.
15. Allen JI, Perri RT, Mc Clain CJ et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983; 102: 577-81.
16. Allen JJ, Kay EN, Macclain CJ. Severe zinc deficiency in humans. Association with a reversible T-lymphocyte dysfunction. Ann Int Med 1981; 95: 154-7.
17. Fabris N, Mocchegiani E, Muzzioli M et al. Zinc, immunity and aging. In Goldstein AL ed. Biomedical Advances in Aging. New York: Plenum, 1990; 271-81.
18. Cunningham-Rundles S, Cunningham-Rundles C, Dupont B. Zinc-induced activation of human B lymphocytes. Clin Immunol Immunopathol 1980; 16: 115-20.
19. Duchateau J, Delespesse G, Vereecke P. Influence of oral zinc supplementation on lymphocyte response to mitogens of normal subjects. Am J Clin Nutr 1981; 34: 88-93.
20. Winchurch RA, Togo J, Adler WH. Supplemental zinc restores antibody formation in cultures of aged spleen cells. II. Effects of mediator production. Eur J Immunol 1987; 17: 127-31.
21. Duchateau J, Delepesse G, Vrijens R et al. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981; 70: 1001-10.
22. Remarque EJ, Witkamp L, Masurel N et al. Zinc supplementation does not enhance antibody formation to influenza virus vaccine in the elderly. Aging Immunol Infect Dis 1993; 4: 17-23.
23. Reynolds JV, Daly KM, Shou J et al. Immunologic effects of arginine supplementation in tumor bearing and non-tumour bearing hosts. Ann Surg 1990; 211: 202-10.
24. Park KGM, Hayes PD, Garlik PJ et al. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991; 337: 645-6.
25. Fabris N, Mocchegiani E, Muzzioli M et al. Recovery of age-related decline of thymic endocrine activity and PHA response by lysine-arginine combination. Int J Immunopharmacol 1986; 8: 677-85.
26. Mocchegiani E, Muzzioli M, Santarelli L et al. Restoring effect of oral supplementation of zinc and arginine on thymic endocrine activity and peripheral immune function in aged mice. Arch Gerontol Geriatr 1992; 3: 267-76.
27. Driessen C, Hirv K, Rink L et al. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res 1994; 13: 15-20.
28. Driessen C, Hirv K, Kirchner H et al. Zinc regulates cytokine induction by superantigens and lipopolyssacaride. Immunology 1995; 84: 272-7.
29. Madore HP, Reichan RC, Dolin R. Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunoadsorbent assay, hemagglutination inhibition and complement fixation. J Clin Microbiol 1983; 18: 1345-50.
30. Fernandez FJ, Khan HL. Clinical methods for atomic absorption spectroscopy. Clin Chem Newslett 1971; 3: 24-9.
31. Evenson MA, Warren BL. Determination of serum copper by atomic absorption with use of the graphite cuvette. Clin Chem 1975; 21: 619-24.
32. McElhaney JE, Beattie BL, Devine R et al. Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc 1990; 38: 652-8.
33. Moccheggiani E, Veccia S, Ancarani F et al. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against some opportunistic infections in AIDS. Int J Immunopharmacol 1995; 17: 719-27.
34. Schloen L, Fernandes G, Garofalo J et al. Nutrition, immune function and cancer - a review, part II. Zinc, immune funcion and cancer. Clin Bul.1979; 9: 63-71.
35. Iwata T, Incefy GS, Tanaka T et al. Circulating thymic hormone levels in zinc deficiency. Cell Immunol 1979; 47: 100-5.
36. Boukaiba N, Flament C, Acher S et al. A physiological amount of zinc supplementation: effects on nutritional, lipid and thymic status in an elderly population. Am J Clin Nutr 1993; 57: 566-72.
37. Fabris N, Mocchegiani E. Arginine-containing compounds and thymic endocrine activity. Thymus 1992; 19: S21-30.